Literature DB >> 20424120

Distinct biological roles for the akt family in mammary tumor progression.

Rachelle L Dillon1, William J Muller.   

Abstract

The phosphatidylinositol 3' kinase/Akt pathway is frequently dysregulated in cancer, which can have unfavorable consequences in terms of cell proliferation, survival, metabolism, and migration. Increasing evidence suggests that Akt1, Akt2, and Akt3 play unique roles in breast cancer initiation and progression. We have recently shown that in contrast to Akt1, which accelerates mammary tumor induction in transgenic mice, Akt2 promotes metastasis of tumor cells without affecting the latency of tumor development. Despite the distinct phenotypic outputs resulting from Akt1 or Akt2 activation, very little is known about the mode by which such unique functions originate from these highly related kinases. Here we discuss potential mechanisms contributing to the differing functional specificity of Akt1 and Akt2 with respect to migration, invasion, and metastasis. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424120      PMCID: PMC2880222          DOI: 10.1158/0008-5472.CAN-10-0266

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex.

Authors:  Claudia Figueroa; Samantha Tarras; Jennifer Taylor; Anne B Vojtek
Journal:  J Biol Chem       Date:  2003-09-21       Impact factor: 5.157

2.  Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT.

Authors:  Merav Yoeli-Lerner; Gary K Yiu; Isaac Rabinovitz; Peter Erhardt; Sebastien Jauliac; Alex Toker
Journal:  Mol Cell       Date:  2005-11-23       Impact factor: 17.970

3.  Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration.

Authors:  Guo-Lei Zhou; David F Tucker; Sun Sik Bae; Kanav Bhatheja; Morris J Birnbaum; Jeffrey Field
Journal:  J Biol Chem       Date:  2006-10-01       Impact factor: 5.157

4.  Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.

Authors:  Ioanna G Maroulakou; William Oemler; Stephen P Naber; Philip N Tsichlis
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

5.  Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration.

Authors:  Jian Li; Bryan A Ballif; Aimee M Powelka; Jun Dai; Steven P Gygi; Victor W Hsu
Journal:  Dev Cell       Date:  2005-11       Impact factor: 12.270

6.  PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.

Authors:  John Brognard; Emma Sierecki; Tianyan Gao; Alexandra C Newton
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

Review 7.  The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer.

Authors:  R L Dillon; D E White; W J Muller
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

8.  Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.

Authors:  John N Hutchinson; Jing Jin; Robert D Cardiff; Jim R Woodgett; William J Muller
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

9.  Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of alpha v beta 3 and alpha 5 beta 1 integrins.

Authors:  Marnie S Roberts; Alison J Woods; Trevor C Dale; Peter Van Der Sluijs; Jim C Norman
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition.

Authors:  Hanna Y Irie; Rachel V Pearline; Dorre Grueneberg; Maximilian Hsia; Preethi Ravichandran; Nayantara Kothari; Sridaran Natesan; Joan S Brugge
Journal:  J Cell Biol       Date:  2005-12-19       Impact factor: 10.539

View more
  81 in total

Review 1.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

2.  Pharmacological inhibition of AKT sensitizes MCF-7 human breast cancer-initiating cells to radiation.

Authors:  Jun-Fang Zhan; Liang-Ping Wu; Long-Hua Chen; Ya-Wei Yuan; Guo-Zhu Xie; Ai-Min Sun; Ying Liu; Zhi-Xian Chen
Journal:  Cell Oncol (Dordr)       Date:  2011-04-15       Impact factor: 6.730

3.  Extracellular heat shock protein 90 signals through subdomain II and the NPVY motif of LRP-1 receptor to Akt1 and Akt2: a circuit essential for promoting skin cell migration in vitro and wound healing in vivo.

Authors:  Fred Tsen; Ayesha Bhatia; Kathryn O'Brien; Chieh-Fang Cheng; Mei Chen; Nissim Hay; Bangyan Stiles; David T Woodley; Wei Li
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

4.  Linoleic acid induces migration and invasion through FFAR4- and PI3K-/Akt-dependent pathway in MDA-MB-231 breast cancer cells.

Authors:  Nathalia Serna-Marquez; Ricardo Diaz-Aragon; Emmanuel Reyes-Uribe; Pedro Cortes-Reynosa; Eduardo Perez Salazar
Journal:  Med Oncol       Date:  2017-04-29       Impact factor: 3.064

5.  Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP.

Authors:  Elena Valentino; Arianna Bellazzo; Giulio Di Minin; Daria Sicari; Mattia Apollonio; Giosuè Scognamiglio; Maurizio Di Bonito; Gerardo Botti; Giannino Del Sal; Licio Collavin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-30       Impact factor: 11.205

6.  AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation.

Authors:  Chia-Wei Li; Weiya Xia; Seung-Oe Lim; Jennifer L Hsu; Longfei Huo; Yun Wu; Long-Yuan Li; Chien-Chen Lai; Shih-Shin Chang; Yi-Hsin Hsu; Hui-Lung Sun; Jongchan Kim; Hirohito Yamaguchi; Dung-Fang Lee; Hongmei Wang; Yan Wang; Chao-Kai Chou; Jung-Mao Hsu; Yun-Ju Lai; Adam M LaBaff; Qingqing Ding; How-Wen Ko; Fuu-Jen Tsai; Chang-Hai Tsai; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2016-01-12       Impact factor: 12.701

7.  Akt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular stores.

Authors:  Victoria A Martin; Wen-Horng Wang; Andrew M Lipchik; Laurie L Parker; Yantao He; Sheng Zhang; Zhong-Yin Zhang; Robert L Geahlen
Journal:  Cell Signal       Date:  2012-01-11       Impact factor: 4.315

8.  MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.

Authors:  Xiaolei Hu; Jie Wang; Wan He; Pan Zhao; Changsheng Ye
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

Review 9.  Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.

Authors:  E-Jean Tan; Anna-Karin Olsson; Aristidis Moustakas
Journal:  Cell Adh Migr       Date:  2014-11-17       Impact factor: 3.405

10.  Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells.

Authors:  Borhane Annabi; Eric Vaillancourt-Jean; Alexander G Weil; Richard Béliveau
Journal:  Onco Targets Ther       Date:  2010-11-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.